Cooper/Haims Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Hold
10,407
0.11% 86
2026
Q1
$263K Hold
10,407
0.12% 78
2025
Q4
$266K Hold
10,407
0.12% 73
2025
Q3
$267K Hold
10,407
0.12% 68
2025
Q2
$263K Hold
10,407
0.13% 68
2025
Q1
$260K Hold
10,407
0.14% 62
2024
Q4
$256K Hold
10,407
0.15% 65
2024
Q3
$268K Hold
10,407
0.15% 66
2024
Q2
$256K Hold
10,407
0.14% 69
2024
Q1
$258K Hold
10,407
0.15% 64
2023
Q4
$263K Hold
10,407
0.15% 58
2023
Q3
$244K Buy
+10,407
New +$251K 0.19% 59

Other funds holding IBDX

Cooper/Haims Advisors's IBDX Position: Q2 2026 in Review

Cooper/Haims Advisors held its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) position steady in Q2 2026 at 10,407 shares worth $262K. The position accounts for 0.11% of the portfolio, ranked #86.

Cooper/Haims Advisors first reported a position in IBDX in Q3 2023 and has held it in 12 quarters since. The position peaked at $268K in Q3 2024. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Cooper/Haims Advisors held 10,407 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $262K as of Q2 2026.
  • Cooper/Haims Advisors left its iShares iBonds Dec 2032 Term Corporate ETF share count unchanged in Q2 2026.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.11% of Cooper/Haims Advisors's portfolio in Q2 2026, its #86 holding.
  • Cooper/Haims Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2023 and has held it in 12 quarters since.
  • Cooper/Haims Advisors's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $268K in Q3 2024.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Cooper/Haims Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.